Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

11C Topotecan PET Imaging

This study has been terminated.
(Drugs unavailable:unable to make radioactive topotecan)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Case Comprehensive Cancer Center Identifier:
First received: November 11, 2005
Last updated: March 16, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)